TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Tuesday reported a loss of $5.8 million in its third quarter. On a per-share basis, the Toronto-based company said it had a loss of $1.85. The drug developer posted revenue of $1.9 million in the period.

TherapeuticsMD: Q3 Earnings Snapshot

Stratasys expects full-year earnings in the range of 3 cents to 7 cents per share, with revenue in the range of $570 million to $580 million. Today on Amazon, you can score early Black Friday savings on this Keurig K-Express

X4 Pharmaceuticals, Inc. (XFOR) on Wednesday reported a loss of $36.7 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of 18 cents. The results fell short of Wall Street expectations.

Assured Guaranty shares have climbed 20% since the beginning of the year. In the final minutes of trading on Monday, shares hit $89.45, a climb of 38% in the last 12 months.

Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $437,000 in its third quarter. The Framingham, Massachusetts-based company said it had a loss of 28 cents per share. The company posted revenue of $614,